What is the role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis?
Valsakumar et al. studied the role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. They found that immunosuppressive therapy was associated with a significant reduction in inflammation, improvement in clinical symptoms, and a decrease in angiographic disease activity. The study concluded that immunosuppressive therapy is an effective treatment for active Takayasu's arteritis and can lead to improved clinical outcomes.